271 related articles for article (PubMed ID: 10455089)
1. Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure.
Murdoch DR; Rooney E; Dargie HJ; Shapiro D; Morton JJ; McMurray JJ
Heart; 1999 Sep; 82(3):352-6. PubMed ID: 10455089
[TBL] [Abstract][Full Text] [Related]
2. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.
McMurray J; Abdullah I; Dargie HJ; Shapiro D
Br Heart J; 1991 Nov; 66(5):356-8. PubMed ID: 1747295
[TBL] [Abstract][Full Text] [Related]
3. Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.
Doehner W; Pflaum CD; Rauchhaus M; Godsland IF; Egerer K; Cicoira M; Florea VG; Sharma R; Bolger AP; Coats AJ; Anker SD; Strasburger CJ
Eur J Endocrinol; 2001 Dec; 145(6):727-35. PubMed ID: 11720897
[TBL] [Abstract][Full Text] [Related]
4. Partial reversal of cachexia by beta-adrenergic receptor blocker therapy in patients with chronic heart failure.
Hryniewicz K; Androne AS; Hudaihed A; Katz SD
J Card Fail; 2003 Dec; 9(6):464-8. PubMed ID: 14966787
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha serum activity during treatment of acute decompensation of cachectic and non-cachectic patients with advanced congestive heart failure.
Parissis JT; Venetsanou KF; Mentzikof DG; Ziras NG; Kefalas CG; Karas SM
Scand Cardiovasc J; 1999; 33(6):344-50. PubMed ID: 10622546
[TBL] [Abstract][Full Text] [Related]
6. Adropin and Irisin in Patients with Cardiac Cachexia.
Kalkan AK; Cakmak HA; Erturk M; Kalkan KE; Uzun F; Tasbulak O; Diker VO; Aydin S; Celik A
Arq Bras Cardiol; 2018 Jul; 111(1):39-47. PubMed ID: 29972412
[TBL] [Abstract][Full Text] [Related]
7. The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia.
Adigun AQ; Ajayi AA
Eur J Heart Fail; 2001 Jun; 3(3):359-63. PubMed ID: 11378008
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin is increased in cardiac cachexia irrespective of body mass index.
Araújo JP; Lourenço P; Rocha-Gonçalves F; Ferreira A; Bettencourt P
Eur J Heart Fail; 2009 Jun; 11(6):567-72. PubMed ID: 19359328
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study.
Christensen HM; Kistorp C; Schou M; Keller N; Zerahn B; Frystyk J; Flyvbjerg A; Faber J
Metabolism; 2014 Jan; 63(1):141-9. PubMed ID: 24140097
[TBL] [Abstract][Full Text] [Related]
10. Ghrelin and leptin levels in cachectic patients with cancer of the digestive organs.
Takahashi M; Terashima M; Takagane A; Oyama K; Fujiwara H; Wakabayashi G
Int J Clin Oncol; 2009 Aug; 14(4):315-20. PubMed ID: 19705241
[TBL] [Abstract][Full Text] [Related]
11. Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia.
Zhao SP; Zeng LH
Int J Cardiol; 1997 Feb; 58(3):257-61. PubMed ID: 9076551
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha.
Doehner W; Rauchhaus M; Godsland IF; Egerer K; Niebauer J; Sharma R; Cicoira M; Florea VG; Coats AJ; Anker SD
Int J Cardiol; 2002 Apr; 83(1):73-81. PubMed ID: 11959387
[TBL] [Abstract][Full Text] [Related]
13. Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis.
Szabó T; Scherbakov N; Sandek A; Kung T; von Haehling S; Lainscak M; Jankowska EA; Rudovich N; Anker SD; Frystyk J; Flyvbjerg A; Pfeiffer AF; Doehner W
Nutr Metab Cardiovasc Dis; 2014 Jan; 24(1):50-6. PubMed ID: 23791298
[TBL] [Abstract][Full Text] [Related]
14. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation.
Anker SD; Coats AJ
Chest; 1999 Mar; 115(3):836-47. PubMed ID: 10084500
[TBL] [Abstract][Full Text] [Related]
15. Leptin serum levels in cachectic heart failure patients. Relationship with tumor necrosis factor-alpha system.
Filippatos GS; Tsilias K; Venetsanou K; Karambinos E; Manolatos D; Kranidis A; Antonellis J; Kardaras F; Anthopoulos L; Baltopoulos G
Int J Cardiol; 2000; 76(2-3):117-22. PubMed ID: 11104865
[TBL] [Abstract][Full Text] [Related]
16. Hyperleptinaemia in chronic heart failure. Relationships with insulin.
Leyva F; Anker SD; Egerer K; Stevenson JC; Kox WJ; Coats AJ
Eur Heart J; 1998 Oct; 19(10):1547-51. PubMed ID: 9820994
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor-kappaB activity in peripheral blood mononuclear cells in cachectic and non-cachectic patients with chronic heart failure.
Siednienko J; Jankowska EA; Banasiak W; Gorczyca WA; Ponikowski P
Int J Cardiol; 2007 Nov; 122(2):111-6. PubMed ID: 17270295
[TBL] [Abstract][Full Text] [Related]
18. The syndrome of cardiac cachexia.
Anker SD; Sharma R
Int J Cardiol; 2002 Sep; 85(1):51-66. PubMed ID: 12163209
[TBL] [Abstract][Full Text] [Related]
19. Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients.
Batista ML; Olivan M; Alcantara PS; Sandoval R; Peres SB; Neves RX; Silverio R; Maximiano LF; Otoch JP; Seelaender M
Cytokine; 2013 Feb; 61(2):532-9. PubMed ID: 23200412
[TBL] [Abstract][Full Text] [Related]
20. Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure.
Valentova M; von Haehling S; Bauditz J; Doehner W; Ebner N; Bekfani T; Elsner S; Sliziuk V; Scherbakov N; Murín J; Anker SD; Sandek A
Eur Heart J; 2016 Jun; 37(21):1684-91. PubMed ID: 26865478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
